2023 Clinic Nuclear Medicine Radiation 
AuntMinnie
JULY 12, 2024
As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclear medicine technologists means a theranostics center may need to limit its patient volume.
AuntMinnie
MARCH 26, 2024
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Imaging Technology
SEPTEMBER 14, 2023
milla1cf Thu, 09/14/2023 - 15:17 September 14, 2023 — Mayo Clinic and GE HealthCare announce a strategic healthcare collaboration for research and product development programs aimed to transform the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies.
Imaging Technology
JULY 3, 2023
milla1cf Mon, 07/03/2023 - 20:06 July 3, 2023 — RefleXion Medical , Inc., milla1cf Mon, 07/03/2023 - 20:06 July 3, 2023 — RefleXion Medical , Inc., professor and chair of City of Hope’s Department of Radiation Oncology. “We professor and chair of City of Hope’s Department of Radiation Oncology. “As
AuntMinnie
APRIL 4, 2024
Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. They're also mindful of the multiple dedicated teams required to build a theranostics clinic properly.
AuntMinnie
JUNE 28, 2024
New imaging and treatment strategies are emerging to prolong the lives of men with metastatic castration-resistant prostate cancer (mCRPC), according to a presentation at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. If you decide to use Xofigo first, you can then use Pluvicto.
Imaging Technology
MAY 12, 2023
milla1cf Fri, 05/12/2023 - 22:07 May 12, 2023 — A newly published meta-analysis indicates that amino acid PET can accurately differentiate recurrent or progressive brain metastases from treatment-related changes. This research was published in the May issue of The Journal of Nuclear Medicine.
Expert insights. Personalized for you.
105 
Let's personalize your content